Einloggen
E-Mail
Passwort
Passwort anzeigen
Merken
Passwort vergessen?
Werden Sie kostenlos Mitglied
Registrieren
Registrieren
Mitglied werden
Kostenlos registrieren
Abonnent werden
Unser Angebot
Einstellungen
Einstellungen
Dynamische Kurse 
OFFON

Business Leaders

Aktuelle NewsUnternehmenMärkteWirtschaft & ForexRohstoffeZinssätzeBusiness LeadersInstitutionelle AnlegerTermineSektoren 
HomeAlle NewsMeistgelesene ArtikelBusiness Leaders Biografien
Übersicht 
Founder of 7 different companies, including: TG Therapeutics, Inc., Cougar Biotechnology, Inc. and Keryx Biopharmaceuticals, Inc. Lindsay Allan Rosenwald is an entrepreneur and businessperson who has been at the head of 13 different companies and currently holds the position of Chairman, President & Chief Executive Officer at Fortress Biotech, Inc., Executive Chairman of Helocyte, Inc., Executive Chairman of Cyprium Therapeutics, Inc. (which he founded in 2017), Executive Chairman for Journey Medical Corp. and President & Chief Executive Officer of Cellvation, Inc. (which are all subsidiaries of Fortress Biotech, Inc.), Executive Chairman for Avenue Therapeutics, Inc. and Partner at Opus Point Partners Management LLC (which he founded in 2009). Dr. Rosenwald is also on the board of Checkpoint Therapeutics, Inc. (former President, Chief Executive Officer & Director), Mustang Bio, Inc. and Caelum Biosciences, Inc.

Lindsay Allan Rosenwald previously occupied the position of Chairman & Chief Executive Officer of Paramount BioCapital, Inc. Chairman & Chief Executive Officer at Paramount BioCapital Asset Management, Inc. and Chairman & Chief Executive Officer at Paramount BioSciences LLC (both are subsidiaries of Paramount BioCapital, Inc.), Co-Chairman & Chief Executive Officer at Origo Acquisition Corp., Managing Director at D.H. Blair & Co., Inc., Chairman of Paramount Acquisition Corp., Securities Analyst at Ladenburg Thalmann & Co., Inc., Director at Keryx Biopharmaceuticals, Inc. and Director at Cougar Biotechnology, Inc.

Dr. Rosenwald received an undergraduate degree from The Pennsylvania State University and a doctorate from Temple University School of Medicine.


Aktuelle Stellungen und Verantwortungsbereiche Lindsay Allan Rosenwald 
NameTitel Seit
Fortress Biotech, Inc.
(Pharmazeutika)
Chairman, President & Chief Executive Officer 2013
Journey Medical Corporation
(Pharmazeutika)
Executive Chairman -
Checkpoint Therapeutics, Inc.
(Biotechnologie)
Non-Executive Director 2015
Mustang Bio, Inc.
(Biotechnologie)
Non-Executive Director 2015
Avenue Therapeutics, Inc.
(Biotechnologie)
Executive Chairman 2015
Opus Point Partners Management LLC Partner 2009
Cellvation, Inc. President & Chief Executive Officer -
Helocyte, Inc. Executive Chairman -
Cyprium Therapeutics, Inc. Executive Chairman 2017
Caelum Biosciences, Inc. Director -


Anteile an Lindsay Allan Rosenwald 
NameAktien%Wert
Fortress Biotech, Inc. (FBIO)
(Pharmazeutika)
10 407 03910,3%33 926 947 USD
Fortress Biotech, Inc. (FBIO.P)
(Pharmazeutika)
92 5002,70%2 400 930 USD
Checkpoint Therapeutics, Inc. (CKPT)
(Biotechnologie)
278 7820,37%978 525 USD
Mustang Bio, Inc. (MBIO)
(Biotechnologie)
218 4230,24%489 268 USD
Avenue Therapeutics, Inc. (ATXI)
(Biotechnologie)
84 6630,50%133 768 USD
Journey Medical Corporation (DERM)
(Pharmazeutika)
00,0000%0 USD


Lindsay Allan Rosenwald: Persönliches Netzwerk 
Meistgelesene News 
15.11.PATRICK DRAHI : Altice-Gründer Drahi strebt größere Beteiligung an der britischen BT an - Quellen
MR
24.11.ELON MUSK : Musk verkauft Tesla-Aktien im Wert von 1,05 Mrd. Dollar und kauft 2,15 Mio. Aktien
MR
24.11.JAMIE DIMON : Jamie Dimon scherzt, dass JPMorgan die Kommunistische Partei Chinas überleben wird
MR
24.11.HERBERT DIESS : Insider - Es steht "Spitz auf Knopf" um Diess als Volkswagen-Chef
RE
17.11.ELON MUSK : Tesla's Musk verkauft weitere 934.000 Aktien, um Steuern zu zahlen, nachdem er Optionen ausgeübt hat - Archivierung
MR
22.11.HERBERT DIESS : Neuer Burgfrieden bei VW in Sicht - Diess soll wohl bleiben
RE
16.11.ELON MUSK : Tesla's Musk verkaufte 934.091 Aktien, um Steuerabzugsverpflichtungen zu erfüllen - Einreichung
MR
24.11.ERIK NORDSTROM : Nordstrom-Gewinn verfehlt Schätzungen aufgrund von Problemen in der Lieferkette, Aktie stürzt ab
MR
29.11.CHRISTIAN KLEIN : SAP-Chef Klein - "SAP wird eines der größten Cloud-Unternehmen der Welt"
RE
18.11.MIUCCIA PRADA : Prada setzt sich ein Umsatzziel von 4,5 Milliarden Euro und will den E-Commerce ausbauen
MR
Weitere Nachrichten


© 2021 People and Ownership :   
Lindsay Allan Rosenwald : Verbindungen